Vladimir Lerner, MD, PhD
- 12Articles
- 65.5KReads
- 1998–2013Active
- 34Collaborators
- 196Citations
About
Vladimir Lerner, MD, PhD, has published extensively on schizophrenia and schizoaffective disorders, with a focus on psychopharmacological treatments and movement disorders associated with these conditions. His research includes clinical trials investigating agents such as bexarotene, L-theanine, pregnenolone, dehydroepiandrosterone, and vitamin B6 for symptom management. Lerner has also studied tardive dyskinesia, akathisia, and other neuroleptic-induced movement disorders, exploring both pharmacologic interventions and biochemical markers. His work spans neurology and psychopharmacology, contributing to a deeper understanding of treatment strategies in psychiatric and neurological comorbidities.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
